- Report
- May 2025
- 182 Pages
Global
From €3111EUR$3,545USD£2,692GBP
€3457EUR$3,939USD£2,991GBP
- Report
- November 2024
- 110 Pages
United States
From €5222EUR$5,950USD£4,518GBP
From €4300EUR$4,900USD£3,721GBP
From €4300EUR$4,900USD£3,721GBP
- Report
- July 2025
Global
From €4300EUR$4,900USD£3,721GBP
- Report
- May 2025
- 187 Pages
Global
From €3111EUR$3,545USD£2,692GBP
€3457EUR$3,939USD£2,991GBP
- Report
- August 2024
- 142 Pages
Global
From €2632EUR$2,999USD£2,277GBP
- Report
- May 2025
- 100 Pages
Global
From €4300EUR$4,900USD£3,721GBP
- Report
- May 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- May 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- April 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- January 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- July 2025
- 182 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 383 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 271 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 296 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 377 Pages
Global
From €5134EUR$5,850USD£4,442GBP

The Autoimmune Disease market within the context of Allergy and Immunology is a rapidly growing field of medical research and treatment. Autoimmune diseases are caused by an overactive immune system, which leads to the body attacking its own healthy cells and tissues. Common autoimmune diseases include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment for autoimmune diseases typically involves immunosuppressive drugs, which reduce the activity of the immune system, and biologics, which target specific parts of the immune system.
In recent years, the development of new treatments for autoimmune diseases has been a major focus of research and development in the Allergy and Immunology field. Companies in this market are focused on developing new treatments, such as monoclonal antibodies, small molecule drugs, and gene therapies. Examples of companies in this market include AbbVie, Amgen, Biogen, Celgene, Gilead, and Regeneron. Show Less Read more